MBDB (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "MBDB" in English language version.

refsWebsite

Global rank English rank

9nih.gov

4^th place

7doi.org

2^nd place

2globenewswire.com

2,614^th place

1,549^th place

1mdma.ch

low place

1erowid.org

3,887^th place

3,197^th place

1uthscsa.edu

low place

1uq.edu.au

3,558^th place

2,403^rd place

1handle.net

102^nd place

76^th place

1who.int

195^th place

302^nd place

1comlaw.gov.au

low place

6,954^th place

1finlex.fi

3,070^th place

5,496^th place

1wikipedia.org

low place

1web.archive.org

1^st place

1notisum.se

low place

comlaw.gov.au

"Poisons Standard". Federal Register of Legislation. Australian Government. October 2015.

doi.org

Oeri HE (May 2021). "Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy". J Psychopharmacol. 35 (5): 512–536. doi:10.1177/0269881120920420. PMC 8155739. PMID 32909493.
Aerts LA, Mallaret M, Rigter H (July 2000). "N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks". Addict Biol. 5 (3): 269–282. doi:10.1111/j.1369-1600.2000.tb00191.x. PMID 20575841.
Nagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain". Eur J Pharmacol. 559 (2–3): 132–137. doi:10.1016/j.ejphar.2006.11.075. PMID 17223101.
Kaur H, Karabulut S, Gauld JW, Fagot SA, Holloway KN, Shaw HE, Fantegrossi WE (2023). "Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder". Psychedelic Medicine. 1 (3). doi:10.1089/psymed.2023.0023. Author Disclosure Statement: H.K. is Vice President of Research at PharmAla Biotech and is listed as an inventor on patents related to the research in this review article. H.E.S. receives salary supported from a contract between PharmAla Biotech and UAMS. W.E.F. receives research funds and salary support from a contract between PharmAla Biotech and UAMS. The other authors have no conflicts to disclose.
Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, Lankri D, Duggan P, Nazarova AL, Cao AB, Calkins MM, Khirsariya P, Hwu C, Katritch V, Chandra SS, McCorvy JD, Sames D (January 2023). "Pharmacological Mechanism of the Non-hallucinogenic 5-HT_2A Agonist Ariadne and Analogs". ACS Chemical Neuroscience. 14 (1): 119–135. doi:10.1021/acschemneuro.2c00597. PMC 10147382. PMID 36521179.
Johnson MP, Nichols DE (May 1989). "Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration". Pharmacol Biochem Behav. 33 (1): 105–108. doi:10.1016/0091-3057(89)90437-1. PMID 2476831.
Lai FY, Erratico C, Kinyua J, Mueller JF, Covaci A, van Nuijs AL (October 2015). "Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs" (PDF). Journal of Pharmaceutical and Biomedical Analysis. 114: 355–75. doi:10.1016/j.jpba.2015.06.016. hdl:10067/1278220151162165141. PMID 26112925.

erowid.org

"MBDB". Erowid Center.

finlex.fi

https://finlex.fi/fi/laki/ajantasa/2014/20141130

globenewswire.com

PharmAla Biotech (23 February 2023). "Patent Application Published for PharmAla Biotech's MDMA Analogs". GlobeNewswire News Room. Retrieved 10 November 2024.
PharmAla Biotech (26 March 2024). "PharmAla Biotech Signs Sale Agreement with Numinus". GlobeNewswire News Room. Retrieved 10 November 2024.

handle.net

hdl.handle.net

Lai FY, Erratico C, Kinyua J, Mueller JF, Covaci A, van Nuijs AL (October 2015). "Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs" (PDF). Journal of Pharmaceutical and Biomedical Analysis. 114: 355–75. doi:10.1016/j.jpba.2015.06.016. hdl:10067/1278220151162165141. PMID 26112925.

mdma.ch

chemistry.mdma.ch

Nichols DE, Marona-Lewicka D, Huang X, Johnson MP (1993). "Novel serotonergic agents" (PDF). Drug Des Discov. 9 (3–4): 299–312. PMID 8400010.

nih.gov

pubmed.ncbi.nlm.nih.gov

Oeri HE (May 2021). "Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy". J Psychopharmacol. 35 (5): 512–536. doi:10.1177/0269881120920420. PMC 8155739. PMID 32909493.
Aerts LA, Mallaret M, Rigter H (July 2000). "N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks". Addict Biol. 5 (3): 269–282. doi:10.1111/j.1369-1600.2000.tb00191.x. PMID 20575841.
Nichols DE, Marona-Lewicka D, Huang X, Johnson MP (1993). "Novel serotonergic agents" (PDF). Drug Des Discov. 9 (3–4): 299–312. PMID 8400010.
Nagai F, Nonaka R, Satoh Hisashi Kamimura K (March 2007). "The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain". Eur J Pharmacol. 559 (2–3): 132–137. doi:10.1016/j.ejphar.2006.11.075. PMID 17223101.
Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, Lankri D, Duggan P, Nazarova AL, Cao AB, Calkins MM, Khirsariya P, Hwu C, Katritch V, Chandra SS, McCorvy JD, Sames D (January 2023). "Pharmacological Mechanism of the Non-hallucinogenic 5-HT_2A Agonist Ariadne and Analogs". ACS Chemical Neuroscience. 14 (1): 119–135. doi:10.1021/acschemneuro.2c00597. PMC 10147382. PMID 36521179.
Johnson MP, Nichols DE (May 1989). "Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration". Pharmacol Biochem Behav. 33 (1): 105–108. doi:10.1016/0091-3057(89)90437-1. PMID 2476831.
Lai FY, Erratico C, Kinyua J, Mueller JF, Covaci A, van Nuijs AL (October 2015). "Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs" (PDF). Journal of Pharmaceutical and Biomedical Analysis. 114: 355–75. doi:10.1016/j.jpba.2015.06.016. hdl:10067/1278220151162165141. PMID 26112925.

ncbi.nlm.nih.gov

Oeri HE (May 2021). "Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy". J Psychopharmacol. 35 (5): 512–536. doi:10.1177/0269881120920420. PMC 8155739. PMID 32909493.
Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, Lankri D, Duggan P, Nazarova AL, Cao AB, Calkins MM, Khirsariya P, Hwu C, Katritch V, Chandra SS, McCorvy JD, Sames D (January 2023). "Pharmacological Mechanism of the Non-hallucinogenic 5-HT_2A Agonist Ariadne and Analogs". ACS Chemical Neuroscience. 14 (1): 119–135. doi:10.1021/acschemneuro.2c00597. PMC 10147382. PMID 36521179.

notisum.se

"Svensk författningssamling" [Swedish Code of Statutes] (PDF) (in Swedish). Notisum AB. Archived from the original (PDF) on 2018-03-06. Retrieved 2013-09-25.

uq.edu.au

espace.library.uq.edu.au

Lai FY, Erratico C, Kinyua J, Mueller JF, Covaci A, van Nuijs AL (October 2015). "Liquid chromatography-quadrupole time-of-flight mass spectrometry for screening in vitro drug metabolites in humans: investigation on seven phenethylamine-based designer drugs" (PDF). Journal of Pharmaceutical and Biomedical Analysis. 114: 355–75. doi:10.1016/j.jpba.2015.06.016. hdl:10067/1278220151162165141. PMID 26112925.

uthscsa.edu

ww2.uthscsa.edu

Clark MR, Shaw HE, Fantegrossi WE (March 2024). Poster 21: In vivo characterization of MBDB and its enantiomers in C57BL/6 and autism-like BTBR T⁺Itpr3^tf/J mice (PDF). 16th Annual Behavior, Biology, and Chemistry: Translational Research in Substance Use Disorders, San Antonio, Texas, Embassy Landmark, 22-24 March 2024.

web.archive.org

"Svensk författningssamling" [Swedish Code of Statutes] (PDF) (in Swedish). Notisum AB. Archived from the original (PDF) on 2018-03-06. Retrieved 2013-09-25.

who.int

whqlibdoc.who.int

WHO Expert Committee on Drug Dependence (2001). "Thirty-second Report, Technical Report Series 903" (PDF).

wikipedia.org

ru.wikipedia.org

ru:MBDB^{[circular reference]}